News
Novo Nordisk announces CEO transition as share price slips
After nearly tripling the company’s value, CEO Lars Fruergaard Jørgensen is preparing to exit amid boardroom shifts. Novo Nordisk announced Friday that it would part ways with its longtime CEO, who steered the company into an unprecedented boom time for weight loss drugs.
Discover why Novo Nordisk A/S' undervalued shares present a buying opportunity, with strong sales growth, profitability, and ...
Novo Nordisk has gone up another gear in its drive to boost manufacturing ... injectables in North Carolina, US. The new plant will be one of the largest manufacturing investments in ...
Zacks Investment Research on MSN11h
Novo Nordisk Stock Gains 14% in a Month: What Should Investors Do?Novo Nordisk NVO shares have gained 13.9% in the past month. Several factors related to the company’s pipeline, regulatory ...
U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it ...
Shares of Novo Nordisk closed around 1% lower on Thursday, while Eli Lilly's stock closed more than 11% lower. It comes as Novo Nordisk works to boost access ... across the US healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results